Analysen zu FTSE 100-Werten

20.09.19 Vodafone Group buy HSBC
20.09.19 GlaxoSmithKline Neutral JP Morgan Chase & Co.
20.09.19 AstraZeneca overweight JP Morgan Chase & Co.
20.09.19 Diageo Halten Independent Research GmbH
20.09.19 Shell (Royal Dutch Shell) (A Outperform Credit Suisse Group
20.09.19 Rolls-Royce Conviction Buy List Goldman Sachs Group Inc.
20.09.19 Unilever Underweight Barclays Capital
20.09.19 Diageo Hold Deutsche Bank AG
19.09.19 London Stock Exchange (LSE buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
19.09.19 Vodafone Group buy HSBC
19.09.19 BAT buy UBS AG
19.09.19 Diageo buy UBS AG
19.09.19 Diageo Neutral JP Morgan Chase & Co.
19.09.19 Reckitt Benckiser Neutral UBS AG
19.09.19 Unilever Neutral UBS AG
19.09.19 International Consolidated Airlines overweight Morgan Stanley
19.09.19 easyJet neutral Morgan Stanley
18.09.19 BAT Outperform Credit Suisse Group
18.09.19 London Stock Exchange (LSE Neutral UBS AG
18.09.19 Unilever Outperform Bernstein Research
18.09.19 Reckitt Benckiser Outperform Bernstein Research
18.09.19 International Consolidated Airlines market-perform Bernstein Research
18.09.19 easyJet market-perform Bernstein Research
17.09.19 BP Outperform Bernstein Research
17.09.19 Shel b Outperform Bernstein Research
17.09.19 easyJet Outperform Credit Suisse Group
17.09.19 HSBC Underweight JP Morgan Chase & Co.
17.09.19 Standard Chartered overweight JP Morgan Chase & Co.
16.09.19 Shell (Royal Dutch Shell) (A overweight JP Morgan Chase & Co.
16.09.19 BP overweight JP Morgan Chase & Co.
16.09.19 AstraZeneca overweight JP Morgan Chase & Co.
16.09.19 BP Outperform Bernstein Research
16.09.19 Shell (Royal Dutch Shell) (A Outperform Bernstein Research
16.09.19 Prudential Neutral JP Morgan Chase & Co.
16.09.19 BP buy Kepler Cheuvreux
16.09.19 Shel b Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
16.09.19 BP buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
16.09.19 easyJet market-perform Bernstein Research
16.09.19 International Consolidated Airlines market-perform Bernstein Research
13.09.19 GlaxoSmithKline Neutral Merrill Lynch & Co., Inc.

Analysen zu Aktien folgender Indizes